ISO/TC 194
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 88200 | ISO 10993-23:2021/Amd 1:2025 | Biological evaluation of medical devices — Part 23: Tests for irritation — Amendment 1: Additional in vitro reconstructed human epidermis models | Standarts spēkā |
| 71514 | ISO/TS 21726:2019 | Biological evaluation of medical devices — Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents | Standarts spēkā |
| 55614 | ISO 10993-3:2014 | Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity | Standarts spēkā |
| 61089 | ISO 10993-6:2016 | Biological evaluation of medical devices — Part 6: Tests for local effects after implantation | Standarts spēkā |
| 63448 | ISO 10993-4:2017 | Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood | Standarts spēkā |
| 75323 | ISO 10993-17:2023 | Biological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constituents | Standarts spēkā |
| 36406 | ISO 10993-5:2009 | Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity | Standarts spēkā |
| 73582 | ISO/TS 37137-1:2021 | Biological evaluation of absorbable medical devices — Part 1: General requirements | Standarts spēkā |
| 71862 | ISO/TR 10993-55:2023 | Biological evaluation of medical devices — Part 55: Interlaboratory study on cytotoxicity | Standarts spēkā |
| 65052 | ISO/TR 10993-33:2015 | Biological evaluation of medical devices — Part 33: Guidance on tests to evaluate genotoxicity — Supplement to ISO 10993-3 | Standarts spēkā |
Displaying 11-20 of 156 results.